Results 91 to 100 of about 666,121 (300)

Survival Results by the Prospectively Determined Clinical Staging for Locally Advanced Gastric Cancer: A Follow‐Up Study of JCOG1302A

open access: yesAnnals of Gastroenterological Surgery, EarlyView.
Prospectively determined clinical T and N categories clearly stratified long‐term survival in locally advanced gastric cancer. Patients with cT3N+, cT4aN0, cT4aN+, and cT4b disease showed unfavorable prognosis despite standard treatment. These findings may help optimize patient selection for perioperative treatment strategies.
Tsutomu Hayashi   +19 more
wiley   +1 more source

Direct Liver Invasion from a Gastric Adenocarcinoma as an Initial Presentation of Extranodal Tumor Spread

open access: yesCase Reports in Medicine, 2012
Gastric cancer often carries a poor prognosis, with an estimated 740,000 deaths from the malignancy occurring yearly worldwide (Dicken et al., 2005). The mortality of disease is largely dependent on the extent of tumor spread, as gastric cancer has a ...
Mitanshu Shah   +6 more
doaj   +1 more source

Comparison of clinicopathological features and treatment of gastric adenocarcinoma between Australia and South Korea

open access: yes, 2012
Many differences in clinicopathological features of gastric cancer and its treatment have been reported between the East and the West however such a comparison using Australian data is still lacking. Gastric cancers seen in Australia differ significantly
Kwon, Sebastianus   +11 more
core  

AI‐Driven Cancer Multi‐Omics: A Review From the Data Pipeline Perspective

open access: yesAdvanced Intelligent Discovery, EarlyView.
The exponential growth of cancer multi‐omics data brings opportunities and challenges for precision oncology. This review systematically examines AI's role in addressing these challenges, covering generative models, integration architectures, Explainable AI for clinical trust, clinical applications, and key directions for clinical translation.
Shilong Liu, Shunxiang Li, Kun Qian
wiley   +1 more source

Comparative immunohistochemical characteristics of Ki-67, p53, caspase-3 expression in gastric hyperplastic polyps and non-invasive intestinal-type gastric adenocarcinoma

open access: yesZaporožskij Medicinskij Žurnal, 2016
Aim. The problem of early diagnostic of gastric cancer has a tight connection with the issue of premalignant lesions, especially gastric polyps. The aim of this research was to compare the expression levels of Ki-67, p53 and caspase-3 in epithelial cells
T. A. Khrystenko
doaj   +1 more source

Gastric adenocarcinoma–GC (H&E—original magnification 40x).

open access: yes, 2016
Gastric adenocarcinoma–GC (H&E—original magnification 40x).
Przemysław Majewski (491153)   +5 more
core   +1 more source

Relative survival rates (%) in patients with oesophageal squamous cell carcinoma, oesophageal adenocarcinoma, gastric cardia adenocarcinoma and gastric non-cardia adenocarcinoma in Sweden in 2000–2008, and follow-up until 2009.

open access: yes, 2013
Relative survival rates (%) in patients with oesophageal squamous cell carcinoma, oesophageal adenocarcinoma, gastric cardia adenocarcinoma and gastric non-cardia adenocarcinoma in Sweden in 2000–2008, and follow-up until 2009.
Jesper Lagergren (287652)   +1 more
core   +1 more source

Tumour-stage specific relative survival rates (%) in patients with oesophageal squamous cell carcinoma, oesophageal adenocarcinoma, gastric cardia adenocarcinoma and gastric non-cardia adenocarcinoma in Sweden in 2004–2008, and follow-up until 2009.

open access: yes, 2013
Tumour-stage specific relative survival rates (%) in patients with oesophageal squamous cell carcinoma, oesophageal adenocarcinoma, gastric cardia adenocarcinoma and gastric non-cardia adenocarcinoma in Sweden in 2004–2008, and follow-up until 2009.
Jesper Lagergren (287652)   +1 more
core   +1 more source

Harnessing ferroptosis from multilayer defense networks to nanoplatforms for specific cancer therapy

open access: yesBMEMat, EarlyView.
Nanomaterials target metabolically‐regulated ferroptosis for cancer therapy. Iron‐based or alternative nanoplatforms integrate ferroptosis with chemotherapy, immunotherapy, or radiotherapy. They enable stimulus‐responsive therapies (photothermal, photodynamic, sonodynamic) activated by near‐infrared, light, or ultrasound, achieving potent synergistic ...
Xinyue Xu   +5 more
wiley   +1 more source

First‐Line Osimertinib in Patients with EGFR‐Mutant Advanced Non‐Small Cell Lung Cancer: Outcome and Safety in the Real World: FLOWER Study

open access: yesThe Oncologist, EarlyView., 2021
Abstract Lessons Learned Osimertinib has confirmed effectiveness in this real‐world population of patients with EGFR‐mutant advanced non‐small cell lung cancer. Thromboembolic events occur more frequently than previously reported, suggesting a thrombotic diathesis that requires further investigation. Patients with at least three metastatic sites, brain
Martina Lorenzi   +21 more
wiley   +1 more source

Home - About - Disclaimer - Privacy